From http://projects.propublica.org/docdollars. © Copyright 2011 Pro Publica Inc.
Payments to Connecticut Health Care Practitioners
This is a listing of all disclosed payments listed for Connecticut
Only showing payments over $250. See all payments ยป
Important notes about this list.
Name/Payee includes both the practitioner listed by the company and the entity receiving payment. If only one name is listed, it represents both the listed practitioner and payee.
| Name / Payee | City | Company | Period | Category | Amount |
|---|---|---|---|---|---|
| BRIDGEPORT HOSPITAL FOUNDATION INC | BRIDGEPORT | Pfizer | 2009 Q3-Q4 | Research | $8,575 |
| CONNECTICUT CHILDREN'S MEDICAL CENTER | HARTFORD | Pfizer | 2009 Q3-Q4 | Research | $11,000 |
| NORWALK HOSPITAL | NORWALK | Pfizer | 2009 Q3-Q4 | Research | $8,754 |
| THE HOSPITAL OF CENTRAL CONNECTICUT | NEW BRITAIN | Pfizer | 2009 Q3-Q4 | Research | $57,970 |
| UNIVERSITY OF CONNECTICUT HEALTH CENTER | FARMINGTON | Pfizer | 2009 Q3-Q4 | Research | $33,063 |
| YALE UNIVERSITY SCHOOL OF MEDICINE | NEW HAVEN | Pfizer | 2009 Q3-Q4 | Research | $132,853 |
| YALE UNIVERSITY SCHOOL OF MEDICINE | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Research | $86,574 |
| YALE UNIVERSITY | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Research | $839,304 |
| UNIVERSITY OF CONNECTICUT HEALTH CENTER | FARMINGTON | Pfizer | 2010 Q1-Q4 | Research | $33,314 |
| NORWALK HOSPITAL | NORWALK | Pfizer | 2010 Q1-Q4 | Research | $9,865 |
| NEW YORK UNIV SCHL OF MED OFF OF CLINICAL TRIALS | HARTFORD | Pfizer | 2010 Q1-Q4 | Research | $3,950 |
| HARTFORD HOSPITAL | HARTFORD | Pfizer | 2010 Q1-Q4 | Research | $5,275 |
| CONNECTICUT CHILDREN'S MEDICAL CENTER | HARTFORD | Pfizer | 2010 Q1-Q4 | Research | $3,500 |
| BRIDGEPORT HOSPITAL FOUNDATION, INC. | BRIDGEPORT | Pfizer | 2010 Q1-Q4 | Research | $12,100 |
| YALE UNIVERSITY SCHOOL OF MEDICINE | NEW HAVEN | Pfizer | 2011 Q1 | Research | $3,800 |
| YALE UNIVERSITY | NEW HAVEN | Pfizer | 2011 Q1 | Research | $45,895 |
| UNIVERSITY OF CONNECTICUT HEALTH CENTER | FARMINGTON | Pfizer | 2011 Q1 | Research | $952 |
| ABELES, ARYEH M | WALLINGFORD | Novartis | 2010 Q4 | Speaking | $2,000 |
| ABELES, ARYEH M | MERIDEN | Pfizer | 2010 Q1-Q4 | Travel | $335 |
| ABELES, ARYEH M | MERIDEN | Pfizer | 2010 Q1-Q4 | Meals | $304 |
| ABELES, ARYEH M | MERIDEN | Pfizer | 2010 Q1-Q4 | Consulting | $2,000 |
| Abeles, Micha | Farmington | AstraZeneca | 2010 Q1-Q4 | Speaking | $1,800 |
| Abeles, Micha | Farmington | AstraZeneca | 2011 Q1 | Speaking | $1,050 |
| Abeles, Micha | West Hartford | Johnson & Johnson | 2010 Q1-Q4 | Consulting | $2,750 |
| ABELES, MICHA / UNIVERSITY OF CONNECTICUT HEALTH CENTER | FARMINGTON | Pfizer | 2010 Q1-Q4 | Research | $12,615 |
| ABELES, MICHA | MERIDEN | Pfizer | 2010 Q1-Q4 | Travel | $572 |
| ABELES, MICHA | MERIDEN | Pfizer | 2010 Q1-Q4 | Meals | $516 |
| ABELES, MICHA | MERIDEN | Pfizer | 2010 Q1-Q4 | Speaking | $7,550 |
| ABRAHAM, RICHARD IRA | CANTON | Pfizer | 2010 Q1-Q4 | Meals | $332 |
| Abramovich, Irene | Simsbury | AstraZeneca | 2010 Q1-Q4 | Speaking | $2,700 |
| Abramovich, Irene | Simsbury | AstraZeneca | 2011 Q1 | Speaking | $1,800 |
| ABRAMOVICH, IRENE | WEST HARTFORD | Eli Lilly | 2009 Q1-Q4 | Speaking | $26,000 |
| ABRAMOVICH, IRENE S | MANCHESTER | Eli Lilly | 2010 Q1-Q4 | Speaking | $42,563 |
| ABRAMOVICH, IRENE S | MANCHESTER | Eli Lilly | 2010 Q1-Q4 | Travel | $4,690 |
| ABRAMOVICH, IRENE S | MANCHESTER | Pfizer | 2011 Q1 | Speaking | $2,050 |
| Abramovich, Irene S. | West Hartford | Johnson & Johnson | 2010 Q1-Q4 | Other | $10,800 |
| Abramovich, Irene S. | West Hartford | Johnson & Johnson | 2010 Q1-Q4 | Travel | $1,111 |
| Abramovich, Irene S. | West Hartford | Johnson & Johnson | 2010 Q1-Q4 | Meals | $528 |
| Abriola, Kenneth | GLASTONBURY | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $500 |
| Abriola, Kenneth | GLASTONBURY | ViiV | 2010 Q1-Q4 | Speaking | $5,250 |
| Abriola, Kenneth P. / Kenneth Patrick Abriola | Hartford | Johnson & Johnson | 2010 Q1-Q4 | Consulting | $1,500 |
| ABU-KHALAF, MAYSA MAHMOUD | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Travel | $367 |
| ABU-KHALAF, MAYSA MAHMOUD | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Consulting | $1,250 |
| ACOSTA, RODRIGO | STAMFORD | Pfizer | 2010 Q1-Q4 | Meals | $265 |
| ADDIS-THOMAS, ELIZA | BRANFORD | Pfizer | 2010 Q1-Q4 | Meals | $327 |
| AGLI, DIANE | PROSPECT | Eli Lilly | 2009 Q1-Q4 | Other | $18,938 |
| AGLI, DIANE | PROSPECT | Eli Lilly | 2010 Q1-Q4 | Other | $2,006 |
| AHLUWALIA, SATWANT | STAMFORD | Eli Lilly | 2009 Q1-Q4 | Consulting | $2,000 |
| Ahmed, Amina | BROOKFIELD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $750 |
| AHUJA, SANGEETA | STAMFORD | Pfizer | 2010 Q1-Q4 | Consulting | $10,238 |
| AHUJA, SANGEETA | STAMFORD | Pfizer | 2011 Q1 | Consulting | $3,150 |
| AL-KHAYER, FADI | STORRS MANSFIELD | Eli Lilly | 2010 Q1-Q4 | Speaking | $26,331 |
| AL-KHAYER, FADI | STORRS MANSFIELD | Eli Lilly | 2011 Q1 | Travel | $258 |
| AL-KHAYER, FADI | STORRS MANSFIELD | Eli Lilly | 2011 Q1 | Speaking | $12,700 |
| Al-Khayer, Fadi | SOUTH WINDSOR | Merck | 2009 Q3-Q4 | Speaking | $2,025 |
| Al-Khayer, Fadi | STORRS MANSFIELD | Merck | 2010 Q1-Q4 | Speaking | $8,775 |
| AL-KHAYER, FADI | SOUTH WINDSOR | Novartis | 2010 Q4 | Speaking | $1,500 |
| AL-KHAYER, FADI AL-ARAB | SOUTH WINDSOR | Eli Lilly | 2009 Q1-Q4 | Speaking | $15,938 |
| Albertsen, Peter | FARMINGTON | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $4,000 |
| ALCANTARA, AURORA FINEZA | STAMFORD | Pfizer | 2009 Q3-Q4 | Speaking | $2,375 |
| ALCANTARA, AURORA FINEZA | STAMFORD | Pfizer | 2009 Q3-Q4 | Travel | $270 |
| Alexander, Nanette | Glastonbury | Cephalon | 2010 Q1-Q4 | Meals | $275 |
| ALEXANDER, NANETTE HUBERT | GLASTONBURY | Pfizer | 2010 Q1-Q4 | Meals | $436 |
| Allen, Jerilyn | WILLIMANTIC | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $1,000 |
| Allen, Jerilyn | WILLIMANTIC | GlaxoSmithKline | 2011 Q1 | Speaking | $3,000 |
| Alleyne, Kenneth | South Windsor | Cephalon | 2009 Q1-Q4 | Other | $367 |
| ALMEIDA, CARLOS SOARES | PROSPECT | Pfizer | 2010 Q1-Q4 | Meals | $357 |
| ALVAREZ, ALEXANDER JOS | PROSPECT | Pfizer | 2010 Q1-Q4 | Meals | $429 |
| AMIR, DORON | BRIDGEPORT | Eli Lilly | 2009 Q1-Q4 | Speaking | $2,000 |
| AMIR, DORON | BRIDGEPORT | Eli Lilly | 2010 Q1-Q4 | Speaking | $6,684 |
| AMIR, DORON | BRIDGEPORT | Novartis | 2010 Q4 | Speaking | $2,000 |
| AMODEO, JOHN PAUL | HAMDEN | Pfizer | 2010 Q1-Q4 | Meals | $367 |
| ANASTASIO, GEORGE DOMENIC | SUFFIELD | Pfizer | 2010 Q1-Q4 | Meals | $301 |
| ANDRUS, PHILLIP D | NEW HAVEN | Eli Lilly | 2010 Q1-Q4 | Consulting | $500 |
| APIADO, MICHELLE LOPEZ | CANTON | Pfizer | 2010 Q1-Q4 | Meals | $266 |
| APPIAH-PIPPIM, JAMES A | BRIDGEPORT | Pfizer | 2009 Q3-Q4 | Speaking | $1,000 |
| APPIAH-PIPPIM, JAMES A | BRIDGEPORT | Pfizer | 2010 Q1-Q4 | Speaking | $1,000 |
| ARCHER-GOODE, CORLIS L | NEW BRITAIN | Pfizer | 2010 Q1-Q4 | Travel | $1,786 |
| ARCHER-GOODE, CORLIS L | NEW BRITAIN | Pfizer | 2010 Q1-Q4 | Meals | $1,031 |
| ARCHER-GOODE, CORLIS L | NEW BRITAIN | Pfizer | 2010 Q1-Q4 | Speaking | $6,250 |
| ARGUELLO, RAUL ANTONIO | DANBURY | Pfizer | 2009 Q3-Q4 | Speaking | $1,250 |
| ARMEL, HARVEY EUGENE | MILFORD | Pfizer | 2011 Q1 | Meals | $256 |
| ARMM, MILTON FRANK | BRIDGEPORT | Pfizer | 2010 Q1-Q4 | Speaking | $1,000 |
| Asaad, Ghazi | Danbury | AstraZeneca | 2010 Q1-Q4 | Speaking | $16,100 |
| Asaad, Ghazi | Danbury | AstraZeneca | 2011 Q1 | Speaking | $7,800 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2009 Q1-Q4 | Speaking | $36,250 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2009 Q1-Q4 | Speaking | $28,200 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2010 Q1-Q4 | Travel | $1,475 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2010 Q1-Q4 | Speaking | $51,988 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2011 Q1 | Travel | $285 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2011 Q1 | Speaking | $6,875 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2011 Q1 | Meals | $417 |
| ASAAD, GHAZI | DANBURY | Eli Lilly | 2011 Q1 | Travel | $316 |
| ASAAD, GHAZI | DANBURY | Pfizer | 2010 Q1-Q4 | Meals | $374 |
| ASAAD, GHAZI | DANBURY | Pfizer | 2010 Q1-Q4 | Speaking | $6,000 |
| ASAAD, GHAZI | DANBURY | Pfizer | 2011 Q1 | Speaking | $1,000 |
| Asgari, Bardia | SHELTON | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $1,500 |
| Awwa, Bassam | New London | AstraZeneca | 2010 Q1-Q4 | Speaking | $7,800 |
| Awwa, Bassam | NEW LONDON | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $16,900 |
| AWWA, BASSAM | STONINGTON | Eli Lilly | 2010 Q1-Q4 | Speaking | $28,800 |
| AWWA, BASSAM | STONINGTON | Eli Lilly | 2010 Q1-Q4 | Travel | $944 |
| AWWA, BASSAM | NEW LONDON | Eli Lilly | 2011 Q1 | Speaking | $4,875 |
| AWWA, BASSAM | NORWICH | Novartis | 2010 Q4 | Speaking | $1,500 |
| AWWA, BASSAM | NEW LONDON | Pfizer | 2010 Q1-Q4 | Travel | $1,432 |
| AWWA, BASSAM | NEW LONDON | Pfizer | 2010 Q1-Q4 | Meals | $406 |
| AWWA, BASSAM | NEW LONDON | Pfizer | 2010 Q1-Q4 | Speaking | $6,750 |
| AWWA, BASSAM | STONINGTON | Pfizer | 2011 Q1 | Speaking | $1,750 |
| Backman, Kenneth | FAIRFIELD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $10,000 |
| Backman, Kenneth | MONROE | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $2,000 |
| Backman, Kenneth | MONROE | GlaxoSmithKline | 2011 Q1 | Speaking | $2,750 |
| Backman, Kenneth Scott | WESTPORT | Merck | 2009 Q3-Q4 | Speaking | $1,025 |
| Backman, Kenneth Scott | FAIRFIELD | Merck | 2010 Q1-Q4 | Speaking | $6,500 |
| BACKMAN, KENNETH SCOTT | WESTPORT | Novartis | 2010 Q4 | Speaking | $3,000 |
| BADGLEY, SHAWNA LEIGH | WATERBURY | Pfizer | 2010 Q1-Q4 | Meals | $370 |
| BAKSH, TERRY | SALEM | Novartis | 2010 Q4 | Speaking | $1,500 |
| BANERJEE, ARJUN | GLASTONBURY | Pfizer | 2010 Q1-Q4 | Meals | $620 |
| Banerjee, Saumitra | BLOOMFIELD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $2,500 |
| Banerjee, Saumitra | BLOOMFIELD | GlaxoSmithKline | 2011 Q1 | Speaking | $2,500 |
| BANKS, KAREN | NORWICH | Eli Lilly | 2010 Q1-Q4 | Travel | $4,251 |
| BANKS, KAREN | NORWICH | Eli Lilly | 2010 Q1-Q4 | Speaking | $9,075 |
| Barr, Alan | STAMFORD | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $600 |
| BARRAK, BECHARA J | HARTFORD | Novartis | 2010 Q4 | Speaking | $1,500 |
| BARRAK, BECHARA J | HARTFORD | Pfizer | 2010 Q1-Q4 | Meals | $1,395 |
| BARRAK, BECHARA J | HARTFORD | Pfizer | 2011 Q1 | Meals | $577 |
| Baskin, Steven | STAMFORD | Merck | 2010 Q1-Q4 | Speaking | $2,025 |
| BASU, SUBRATA KUMAR | HARTFORD | Pfizer | 2010 Q1-Q4 | Meals | $1,082 |
| BEAUSOLEIL, SHANNON B | ENFIELD | Pfizer | 2010 Q1-Q4 | Meals | $636 |
| BEHRENDS, ROBERT WILLIAMS | WATERBURY | Pfizer | 2010 Q1-Q4 | Meals | $285 |
| BELLANTUONO, MELISA A. | FARMINGTON | Eli Lilly | 2009 Q1-Q4 | Other | $1,238 |
| BENAVIV-MESKIN, DANIELLE | BRIDGEPORT | Eli Lilly | 2009 Q1-Q4 | Speaking | $10,775 |
| BENAVIV-MESKIN, DANIELLE | BRIDGEPORT | Eli Lilly | 2011 Q1 | Travel | $1,034 |
| BENAVIV-MESKIN, DANIELLE | BRIDGEPORT | Eli Lilly | 2011 Q1 | Speaking | $3,525 |
| BENAVIV-MESKIN, DANIELLE | FAIRFIELD | Novartis | 2010 Q4 | Speaking | $1,500 |
| BENAVIV-MESKIN, DANIELLE P | BRIDGEPORT | Eli Lilly | 2010 Q1-Q4 | Speaking | $12,338 |
| Bennett, Steven J | Greenwich | Cephalon | 2009 Q1-Q4 | Other | $500 |
| Benton, Brian | Lisbon | AstraZeneca | 2010 Q1-Q4 | Speaking | $10,600 |
| Benton, Brian T. | Norwich | Johnson & Johnson | 2010 Q1-Q4 | Speaking | $9,050 |
| Benton, Brian T. | Norwich | Johnson & Johnson | 2010 Q1-Q4 | Meals | $338 |
| Benton, Brian T. | Norwich | Johnson & Johnson | 2010 Q1-Q4 | Travel | $298 |
| BENTON, BRIAN THEODORE | NORWICH | Pfizer | 2010 Q1-Q4 | Meals | $343 |
| BENTON, BRIAN THEODORE | NORWICH | Pfizer | 2010 Q1-Q4 | Speaking | $3,000 |
| BENTON, BRIAN THEODORE | NORWICH | Pfizer | 2011 Q1 | Speaking | $2,000 |
| BERMAN, JEFFREY N | FAIRFIELD | Eli Lilly | 2010 Q1-Q4 | Speaking | $7,784 |
| BERMAN, JEFFREY N. | TRUMBULL | Eli Lilly | 2009 Q1-Q4 | Speaking | $2,425 |
| Bia, Frank | GUILFORD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $2,500 |
| Bilbool, Norma | Norwalk | Cephalon | 2010 Q1-Q4 | Meals | $348 |
| Bilchik, Tanya | EAST HARTFORD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $22,300 |
| Bilchik, Tanya | EAST HARTFORD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $13,800 |
| Bilchik, Tanya | EAST HARTFORD | GlaxoSmithKline | 2011 Q1 | Speaking | $1,500 |
| BILCHIK, TANYA ROCHELLE | EAST HARTFORD | Allergan | 2010 Q3-Q4 | Combination | $1,001-$10,000 |
| Bilchik, Tanya Rochelle | NORTH HAVEN | Merck | 2009 Q3-Q4 | Speaking | $9,175 |
| Bilchik, Tanya Rochelle | EAST HARTFORD | Merck | 2010 Q1-Q4 | Speaking | $10,325 |
| BINDER, HENRY JOS | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Consulting | $2,166 |
| Blick, Gary / Circle Medical, Llc | NORWALK | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $2,000 |
| Blick, Gary / Circle Medical, Llc | NORWALK | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $67,750 |
| Blick, Gary / Circle Medical, LLC | Norwalk | Johnson & Johnson | 2010 Q1-Q4 | Consulting | $3,000 |
| Blick, Gary | Norwalk | Johnson & Johnson | 2010 Q1-Q4 | Speaking | $12,500 |
| BLICK, GARY / CIRCLE MEDICAL LLC | NORWALK | Pfizer | 2009 Q3-Q4 | Speaking | $875 |
| Blick, Gary / Circle Medical, LLC | NORWALK | ViiV | 2010 Q1-Q4 | Consulting | $5,000 |
| Blick, Gary / Circle Medical, LLC | NORWALK | ViiV | 2010 Q1-Q4 | Speaking | $62,250 |
| Bloom, Ronald | West Hartford | AstraZeneca | 2010 Q1-Q4 | Speaking | $1,000 |
| Bloom, Ronald | BLOOMFIELD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $4,000 |
| BLOOM, RONALD | BLOOMFIELD | Eli Lilly | 2009 Q1-Q4 | Speaking | $1,075 |
| BLOOM, RONALD J | WINDSOR LOCKS | Eli Lilly | 2010 Q1-Q4 | Speaking | $934 |
| BLOOM, RONALD JEFFREY | BLOOMFIELD | Pfizer | 2010 Q1-Q4 | Meals | $305 |
| BLUMBERG, JEFFREY | NEW HAVEN | Pfizer | 2011 Q1 | Speaking | $6,000 |
| BLUME, PETER A | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Travel | $931 |
| BLUME, PETER A | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Meals | $1,016 |
| BLUME, PETER A | NEW HAVEN | Pfizer | 2010 Q1-Q4 | Speaking | $15,500 |
| BLUME, PETER A | NEW HAVEN | Pfizer | 2011 Q1 | Speaking | $2,000 |
| Bogdanovics, Egils / DIABETES & ENDOCRINOLOGY OF NW CT LLC | Torrington | AstraZeneca | 2010 Q1-Q4 | Speaking | $9,500 |
| Bonwetsch, Robert | DANBURY | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $1,250 |
| BOOLBOL, ROBERT J | FARMINGTON | Pfizer | 2010 Q1-Q4 | Meals | $288 |
| Boruchov, Adam | HARTFORD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $5,500 |
| Bosco, Peter | HARTFORD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $12,500 |
| Bosco, Peter | HARTFORD | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $10,000 |
| Bosco, Peter | HARTFORD | GlaxoSmithKline | 2011 Q1 | Speaking | $2,500 |
| BRAMMER, ROBIN M | MILFORD | Pfizer | 2010 Q1-Q4 | Meals | $329 |
| Brandt, Douglas | Mystic | AstraZeneca | 2010 Q1-Q4 | Speaking | $5,900 |
| BREEN, JEANNE DEMARS | WEST HARTFORD | Pfizer | 2010 Q1-Q4 | Consulting | $24,863 |
| BREEN, JEANNE DEMARS | WEST HARTFORD | Pfizer | 2011 Q1 | Consulting | $2,592 |
| BRENNAN, BRUCE THOMAS | ANSONIA | Pfizer | 2010 Q1-Q4 | Meals | $275 |
| BRENNAN, BRUCE THOMAS | ANSONIA | Pfizer | 2011 Q1 | Meals | $322 |
| Brennan, Michael | Fairfield | Cephalon | 2010 Q1-Q4 | Consulting | $700 |
| Brennan, Michael | Fairfield | Cephalon | 2011 Q1-Q2 | Travel | $827 |
| Brennan, Michael | Fairfield | Cephalon | 2011 Q1-Q2 | Consulting | $5,000 |
| Brennan, Michael | Fairfield | Cephalon | 2011 Q1-Q2 | Speaking | $8,650 |
| BRENNAN, MICHAEL J / MICHAEL J. BRENNAN, M.D. | FAIRFIELD | Eli Lilly | 2010 Q1-Q4 | Speaking | $450 |
| Brennan, Michael J. | Fairfield | Johnson & Johnson | 2010 Q1-Q4 | Speaking | $13,750 |
| Brennan, Michael J. | Fairfield | Johnson & Johnson | 2010 Q1-Q4 | Travel | $482 |
| BRENNAN, MICHAEL J. | FAIRFIELD | Eli Lilly | 2009 Q1-Q4 | Speaking | $22,050 |
| BRENNAN, MICHAEL JOS | FAIRFIELD | Pfizer | 2009 Q3-Q4 | Speaking | $1,250 |
| BRENNAN, MICHAEL JOS | FAIRFIELD | Pfizer | 2010 Q1-Q4 | Speaking | $1,250 |
| BREW, PATRICK | STAMFORD | Pfizer | 2009 Q3-Q4 | Meals | $387 |
| BREW, PATRICK | STAMFORD | Pfizer | 2009 Q3-Q4 | Travel | $426 |
| BREWER, MOLLY ALEXANDER | FARMINGTON | Eli Lilly | 2009 Q1-Q4 | Speaking | $6,450 |
| BROOKS, NEIL H | MANCHESTER | Eli Lilly | 2010 Q1-Q4 | Consulting | $2,000 |
| BROOKS, NEIL H. | VERNON | Eli Lilly | 2009 Q1-Q4 | Consulting | $4,000 |
| BROWN, ANGELA CHRISTI | NORWALK | Pfizer | 2010 Q1-Q4 | Meals | $348 |
| BROWN, THOMAS E | HAMDEN | Eli Lilly | 2010 Q1-Q4 | Consulting | $27,938 |
Notes
- Companies are continually updating their data, so the most recent additions may not be included in our database.
- The reports include both the name of the health provider who performed the service as well as the entity paid. They may be different.
- A physician on the list may be getting money from other companies that have yet to disclose payments.
- Practitioner names and addresses (city/state) are listed as the companies released them and may vary. For instance, some companies include a middle initial, and others do not. Some companies also list different cities for the same individual. This may happen because professionals may have practices in multiple locations or because they provided different addresses for payment.